Method Validation of Esomeprazole Analysis in Human Plasma using High Performance Liquid Chromatography–Photodiode Array
1, 1, 1
- 1Faculty of Pharmacy, University of Indonesia, UI Depok Campus, Depok, 16424, INDONESIA.
CORRESPONDENCE
Received: 21-12-2016; Revised: 07-01-2017; Accepted: 13-01-2017.
Volume 9, Issue 1s · pp. s24-s28 · 2017 · DOI: 10.5530/jyp.2017.1s.7
ABSTRACT
Objective: This research aimed to develop sensitive, simple, and selective methods for determination of esomeprazole in human plasma using lansoprazole as internal standard by high performance liquid chromatography.Method: The analytical separation was performed on C-18 column (Waters, Sunfire™ 5 μm; 250 x 4.6 mm), column temperature 40°C. The mobile phase used acetonitrile - phosphate buffer pH 7.6 (40: 60% v/v) with a flow rate of 1.00 mL/min; and photodiode array detector at a wavelength of 300 nm. Esomeprazole and lansoprazole were extracted by liquid-liquid extraction using dichloromethane.Results: The method had a chromatographic run time of 10 min and linear calibration curve over the range of 5.0-450 ng/mL with a correlation coefficient (r) of 0.999 or better. The sensitivity, specificity, linearity, precision and accuracy, recovery and stability were validated for esomeprazole in human plasma.Conclusion: The results of validation fulfilled the acceptance criteria of validation method based on EMEA Bioanalytical Guideline 2011.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Harahap, Y., Baskara, A. E., & h, H. (2017). Method Validation of Esomeprazole Analysis in Human Plasma using High Performance Liquid Chromatography–Photodiode Array. Journal of Young Pharmacists, 9(1s), s24-s28. https://doi.org/10.5530/jyp.2017.1s.7
Copyright and licence
© 2017 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0